Catalyst Wire Dossier Catalyst Wire Dossier

aripiprazole (OPC-14597)

aripiprazole · Otsuka Pharmaceutical Development & Commercialization, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for aripiprazole (OPC-14597), covering 2018-08-08 to 2018-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder [Phase 3]

See pricing